Diabetes mellitus (DM) is an ideal instance of a persistent illness that represents a big burden on people and healthcare programs within the European Union and past, contemplating each insurance-based and Nationwide Healthcare Service (NHS)-based healthcare programs. In line with the Worldwide Diabetes Federation, and contemplating sort 2 diabetes mellitus (T2DM), in Europe nearly 60 million individuals have T2DM and the quantity is projected to exceed 70 million by 2045, as extra individuals stay longer and develop heavier.1
The first goal of T2DM people care, and consequently of antiglycemic oral therapies, is the achievement and the upkeep of glycemia in goal, regulating blood glucose, and retaining glycaemia at (or beneath) the share of all haemoglobin that’s glycated contemplating the goal of seven% (53 mmol/mol). Strict glycaemic management in people with T2DM decreases the incidence of diabetic issues, which may decide the standard of life and prognosis of such persistent inhabitants.2,3
With regard to T2DM glycaemic management, historically, glycated haemoglobin (HbA1c), is a crucial indicator for long-term glucose monitoring, representing, along with fasting plasma glucose (FPG), the usual panel of in vitro diagnostics devices for this particular setting.4–9 Nevertheless, HbA1c will not be appropriate for the analysis of short-term variations of glycaemic management due to the lengthy lifespan of erythrocyte.4,10,11
Over the previous few years, an progressive glycaemic marker has emerged in medical apply, which is helpful for monitoring glycaemic management in T2DM people:6 glycated albumin (GA), to be carried out along with the above-mentioned conventional monitoring devices (HbA1c and FPG), as an add-on technique. GA, a ketoamine fashioned by non-enzymatic glycation of serum albumin, displays short-term (2–3 weeks) imply glycaemic ranges.12,13 Moreover, GA values will not be affected by modifications in erythrocyte lifespan,14 and measurement of GA isn’t influenced by anaemia or different people’ medical circumstances or comorbidities (i.e. people with diabetes on dialysis), which may invalidate HbA1c measurements, within the analysis and monitoring of diabetes.15,16
Therefore, this assay precisely displays glycaemic management in T2DM people, whether or not their antihyperglycemic regimens are secure or being modified to enhance management, thus additionally predicting future HbA1c ranges, and consequently being useful to clinicians wishing to guage early remedy responses or predict deteriorations in glycaemic management.17 Regardless of the significance of this progressive glycaemic marker, at current, its use within the Italian medical apply isn’t but standardized. Conversely, Asian Nations, comparable to Japan and China, have already utilized this progressive glycaemic marker in routine apply, with its inclusion in particular country-oriented tips and proposals, in addition to a consequent particular reimbursement tariff improvement.18–20
Subsequently, an in-depth examine is required, notably within the European setting, with a particular concentrate on Italy, because the Italian context represents the second In Vitro Diagnostic (IVD) market, after Germany, thus being the proper location to guage the potential GA diffusion and impacts in each insurance-based and NHS-based healthcare programs.21 That is in line with the European regulation on medical gadgets, reporting that when a product has confirmed its security, efficacy and high quality, it could must undergo an analysis of its worth in contrast with present healthcare interventions, earlier than being granted full entry to markets.22 The governments, each at native and central degree, would consider and take into account solely these improvements that have been in a position to show their value-for cash, and cost-effectiveness.23
Past these premises, the examine goals at defining the potential advantages of GA introduction within the Italian medical apply, as an add-on know-how to the normal glycaemic monitoring programs (Hb1Ac and FPG), thus creating consensus with regard to its routinely use in monitoring T2DM people, and answering to the next coverage query:
May GA be thought-about an applicable and sustainable glycaemic marker to be carried out throughout the Italian NHS, for the enough monitoring exercise of T2DM insulin-naïve people?
This might help the decision-making technique of all European and worldwide Nations not but utilizing GA, by offering evidence-based info, with regard to its effectiveness, security, effectivity and sustainability.
A Well being Know-how Evaluation (HTA) was carried out in 2018–2019, contemplating the Italian NHS perspective and specializing in insulin-naïve people affected by T2DM diabetes, handled with oral therapies.
Because of the multi-dimensional and multi-disciplinary nature of an HTA, a number of points of the medical applied sciences have been thought-about, as acknowledged throughout the EUnetHTA Core Mannequin.23 The next dimensions have been analysed: i) relevance of the well being downside; ii) technical description of the applied sciences underneath evaluation; iii) security; iv) efficacy and effectiveness; v) financial and monetary impression; vi) fairness; vii) authorized points; viii) social and moral impression; and ix) organisational impression.
A Concentrate on the Evaluation of the Dimensions
The above dimensions have been deployed contemplating the next methodological approaches.
a) A scientific literature evaluation was carried out, to retrieve the security and the efficacy profiles of each the normal devices and the GA add-on technique potential impression, in addition to to determine the goal inhabitants eligible to GA use.
The PICO strategy (Downside/inhabitants, Intervention, Comparator and End result) for literature retrieval was recognized:24,25 i) P (inhabitants) – insulin-naïve people affected by T2DM, handled with oral therapies; ii) I (intervention) – introduction of GA to be carried out with Hb1Ac and FPG; iii) C (comparator) – conventional panel of devices for glycaemic management (Hb1Ac and FPG); iv) O (consequence) – medical effectiveness, when it comes to fee of people attaining therapeutic success after 3 months of remedy.
Literature proof got here from a scientific search of literature databases (PubMed, Embase and Cochrane Library), from 2011 as much as December 2020, contemplating the next search technique: “glycosylated serum albumin”[Supplementary Concept] OR “glycosylated serum albumin”[All Fields] OR “glycated albumin”[All Fields]. Moreover consistency with the search technique, the outlined inclusion standards have been the next: i) variety of sufferers enrolled within the examine (> 20); ii) journal impact-factor (> 1); iii) examine design and readability of the comparative declare. As soon as recognized the papers to be included within the HTA, an impartial validation of the scientific proof accessible on the subject was carried out, by the CASP (Important Appraisal Expertise Programme) guidelines, with the help of seven consultants (3 methodological consultants, 2 diabetologists and a pair of laboratory consultants).26
b) Well being economics instruments have been used for the financial analysis of the medical pathway and for finances impression evaluation. The medical pathway was outlined when it comes to customary procedures carried out by T2DM people, in keeping with structured interviews with 5 clinicians, referring to five Italian hospitals. A ultimate approval and settlement from the clinicians of reference, in accordance with a Delphi strategy,27 was retrieved, contemplating the next gadgets that have been mapped. i) Quantity and typology of blood/laboratory exams; ii) quantity and typology of diagnostic procedures; iii) quantity and typology of diabetic visits and different specialist visits; and iv) quantity and typology of self-monitoring of blood glucose. The usual medical pathway, associated to the implementation of solely conventional devices, was carried out and evaluated, evaluating the medical pathway of the people who haven’t skilled a remedy change inside a 12-month time horizon of remedy and monitoring, and the medical pathway of the people who’ve skilled a remedy change, through the 12-month time horizon of remedy and monitoring. It must be famous right here that the therapeutic change fee was hypothesized from scientific literature, when it comes to diabetic people deemed to not have an efficient response to the present oral remedy, since they didn’t obtain the glycemia in goal.28 Moreover, the progressive medical pathway with GA introduction, was additionally hypothesised and accordingly valorised, ranging from the normal strategy pathway evaluation, thus defining doable modifications within the variety of blood exams specialist visits or diagnostic procedures. The above financial info was evaluated, in accordance with outpatients/hospital admission Nationwide Reimbursement Tariffs, already legitimate for years 2020–2021.29
The financial analysis of the 2 medical pathways was built-in with a cost-effectiveness evaluation and a finances impression evaluation. On one hand, the cost-effectiveness worth indicator (CEV), in common phrases, was decided with a purpose to select the know-how that exhibits a greater cost-effectiveness trade-off (calculated as value per T2DM particular person divided by the efficacy indicator, when it comes to proportion of people attaining therapeutic success after 3 months of remedy), for each eventualities. Then again, the finances impression evaluation in contrast the “AS IS” state of affairs (use of solely the normal devices), with the “TO BE” state of affairs (introduction of the GA check along with the normal panel of devices), with a purpose to outline the financial sustainability of the progressive marker. A 100% alternative fee was assumed, for the introduction of the brand new know-how, and the variety of eligible T2DM people was decided, primarily based on the Italian epidemiological T2DM prevalence charges accessible within the nationwide proof.29,30
c) Administration of qualitative questionnaires crammed out by 15 healthcare T2DM diabetes consultants (5 laboratory consultants, 1 epidemiologist, 5 diabetes clinicians, 2 strategic instructions, 2 consultant of sufferers associations), consultant of all of the stakeholders throughout Italy (referring to each private and non-private hospitals) who’ve particular data of using GA, due to their involvement in experimental research on the subject.
The qualitative questionnaires have been used for inspecting clinicians’ perceptions on fairness, social, authorized, and organisational points, contemplating a comparative strategy of the 2 panels of know-how being assessed, in accordance with a 7-item Likert scale starting from – 3 to +3.31
All of the gadgets used for the deployment of every qualitative dimension, derived from the EUnetHTA Core Mannequin points,23 with particular integrations and modifications, in relation with the character of the know-how being assessed.
The above qualitative methodology was helpful to gather a variety of concepts and opinions that people perform about points and subjects, in addition to reveal viewpoint variations amongst stakeholders’ teams.32–34 Moreover, for underneath found analysis areas, qualitative strategies try and fill in gaps which might be left unexposed by survey-based analysis, in addition to literature proof.35
A Concentrate on the Statistical Strategies
Knowledge have been first synthetized, contemplating descriptive statistics. Statistically vital variations have been analyzed, utilizing parametric or not parametric exams, relying on the conventional distribution of the variables investigated.
With regard to the financial dimension, a sensitivity evaluation was carried out, by the use of Bayesian strategies, helpful to supply a whole paradigm for each statistical inference and determination making underneath uncertainty.36,37 Gamma distributions have been accordingly developed, with a purpose to confirm the robustness of the outcomes, in presence of uncertainty components (medical pathway value and CEV parameters have been analyzed). The chance to have: i) any common value worth of the gamma distribution of the progressive panel of know-how, decrease with respect to the normal one, and ii) any common CEV of the gamma distribution of the progressive panel of know-how, decrease with respect to the normal one, was evaluated.
Outcomes from Literature Evaluation
The seek for Mesh phrases resulted in 612 data. Out of them, solely 50 have been assessed for eligibility. In accordance with the above-mentioned search technique, solely 5 articles13,28,38–41 met the inclusion standards outlined within the methodology part, specializing in the precise use of GA for T2DM insulin-naïve people and evaluating GA and HbA1c, as offered within the Prisma Movement Chart (Supplementary Figure 1). The opposite 45 articles had totally different goals, with out focusing the eye on efficacy/security information, however presenting sensibility and specificity info, in regards to the presence of a strict correlation between GA and HbA1c.
Literature evaluation acknowledged that the introduction of GA as add-on technique may enhance each security and the efficacy profiles, as compared with using solely conventional monitoring devices.
From a security standpoint, GA may very well be a greater relative danger predictor within the improvement of diabetes issues in contrast with utilizing HbA1c alone, contemplating diabetic retinopathy, nephropathy, and cardiovascular occasions improvement.42–46
From an efficacy standpoint, GA would improve the variety of people attaining therapeutic success after three months of remedy (97.0% vs 71.6%), – when it comes to people deemed to have efficient response to oral remedy – with a consequent lower in individuals with diabetes requiring a therapeutic change.28 This is able to strengthen the consideration that GA is a helpful marker for the monitoring actions of diabetes, thus having the ability to decide the effectiveness of remedy earlier than initiating or altering treatment for people with diabetes.12,47 Certainly, there could also be no discernible discount within the HbA1c degree till a number of weeks after beginning remedy, which can delay the dedication of whether or not the precise therapeutic routine is efficient.28
Outcomes from the Well being Economics Analysis
The financial analysis of the “AS IS” and the “TO BE” state of affairs is detailed in Table 1, thus revealing a statistically vital distinction between a person who has not skilled a remedy change inside a 12-month time horizon and a person who has skilled a remedy change inside a 12-month time horizon, in each eventualities (p-value = 0.000).
Desk 1 Financial Analysis of the Diabetic Particular person’s Scientific Pathway Derived from Delhi Method Implementation
Within the comparability between the weighted common value, contemplating the therapeutic change incidence fee,28 when it comes to diabetic people not attaining an oral response remedy, no statistically vital variations emerged (€ 233.08 vs € 230.61, p-value > 0.05). Nevertheless, sensitivity evaluation experiences that the progressive medical pathway panel offered a chance to soak up decrease financial sources equal to 74.53%, contemplating a 12-month time horizon (Figure 1).
Determine 1 Gamma distributions for prices.
Table 2 experiences that the progressive panel of know-how may very well be the preferable answer to be adopted from a cost-effectiveness standpoint, thus at all times presenting the higher trade-off between prices and effectiveness, with respects to the normal devices (Figure 2).
Desk 2 Value-Effectiveness Evaluation
Determine 2 Gamma distributions for cost-effectiveness worth.
Whereas a CEA evaluates each prices and outcomes of other applied sciences over a specified time horizon, to estimate their financial effectivity, a finances impression evaluation (BIA) is predicated on their affordability inside a particular setting.
Based mostly on the Italian inhabitants in 2018 and the diabetes prevalence fee, equal to five.3%,30 3,205,651 Italian people endure from T2DM diabetes. Out of them, 61% are being handled with oral therapies,31 thus leading to 1,955,447 people, who may very well be potential customers of the brand new GA glycaemic biomarker.
Given the financial analysis beforehand talked about, in addition to the share of people experiencing a remedy change, the GA check introduction would result in fewer people requiring a remedy change (−89.44%), with an financial benefit of 1.06% (in a 12-month time horizon). The Italian NHS may save € 4,835,985, by the correct medical administration of 1,955,447 sort 2 diabetic insulin-naïve people, handled with oral remedy (Table 3).
Desk 3 Price range Influence Evaluation
Outcomes from the Qualitative Evaluation
The evaluation of the qualitative perceptions of the healthcare professionals concerned (Table 4) (as already defined, contemplating a 7-item Likert Scale, starting from – 3 to + 3), reported that the normal devices may very well be thought-about the preferable know-how (0.72 vs 0.13, p-value > 0.05), from an fairness perspective. This consideration could also be justified by restricted accessibility to GA (−0.42 vs 1.83, p-value = 0.000), because the progressive know-how has not but been used and carried out within the Italian laboratories. In distinction, GA may very well be the preferable glycaemic marker, contemplating the professionals’ notion on the merchandise “existence of things limiting using the know-how” (1.33 vs 0.67, p-value = 0.000), masking a bigger inhabitants. The truth is, GA isn’t influenced by erythrocyte lifespan, nor by anaemia, or different people’ medical circumstances, which invalidate HbA1c measurements, within the monitoring of diabetes.12,45,48–50
Desk 4 Qualitative Evaluation of the Fairness, Moral, Social and Authorized Impacts
The introduction of a GA check would enhance the standard of lifetime of each people with diabetes (1.33 vs 2.17, p-value = 0.000) and caregivers (0.83 vs 1.50, p-value = 0.000), since it’s associated to higher glycaemic management monitoring and a decrease relative danger of growing diabetes-related issues and adversarial occasions.
An evaluation of the authorized implications reported that the 2 applied sciences underneath evaluation may very well be thought-about super-imposable of their measurement (p-value > 0.05). Further authorized efforts are required concerning the regulation of GA acquisition.
Specializing in the organisational dimension (Table 5), within the quick time period (12 months), the GA check acquired a decrease rating than the comparator, because it wants further investments in coaching programs for all those that are concerned within the process (−0.80 vs 0.10, p-value = 0.036). A element that impacts considerably on the organisation gave the impression to be the acquisition of the brand new know-how (−0.20 vs 0.00, p-value > 0.05), in addition to the updating of laboratory gear at present in use (−0.50 vs 0.00, p-value > 0.05), even when no statistically vital variations emerged. Nevertheless, the implementation and the adoption of GA in medical apply would permit an enchancment within the diabetic people’ medical pathway (0.90 vs 0.10, p-value = 0.015).
Desk 5 Organisational Influence
Over a 36-month time-period from market penetration, there was a contraction within the above-mentioned drawbacks. The healthcare professionals, having turn into competent at utilizing the progressive know-how, not must attend coaching programs. On this view, it emerges that the progressive know-how could also be thought-about probably the most most well-liked various from an organisational standpoint, with a mean worth of 0.30 (p-value = 0.018).
The outcomes of the examine generate an fascinating scientific contribution, thus masking an necessary data hole, concerning the implementation of GA check, in medical apply, for glycaemic management in insulin-naïve people affected by T2DM. That is notably necessary, as a result of each early analysis of diabetes and strict glucose management are essential for stopping or delaying the onset of significant, even life-threatening issues.51 On this view, the HTA outcomes strengthen this consideration, displaying that the introduction of GA along with the normal devices for glycaemic management could also be thought-about a legitimate technological various, for the remedy of T2DM individuals with diabetes. As acknowledged in literature proof, the introduction of GA as an add-on know-how presents benefits in each security and efficacy profiles, with a consequent optimistic impression, regarding each the financial and the person’s perspective.3,28,38–41
Outcomes have demonstrated the feasibility and the sustainability of GA introduction into the medical apply, revealing the necessity for much less funding associated to its acquisition. Further benefits of GA over HbA1c are represented by its comparable prices, and by the chance to course of the GA check utilizing typical laboratory medical chemistry analysers, with out further organisational effort and being in line with literature proof accessible on the subject.51 In line with that, the finances impression evaluation confirmed that the funding for GA routine implementation may very well be absorbed throughout the first yr after its introduction, thus additionally resulting in financial benefits associated to the optimisation of the medical pathway of T2DM insulin-naïve people, handled with oral therapies. This financial benefit may subsequently be variable from a minimal of 1.06% to a most of 4.58%, strictly depending on the variety of individuals with diabetes requiring a therapeutic change.
Then again, increased perceptions concerning the moral and social profile of GA introduction emerged: it will enhance the standard of lifetime of each people with diabetes and the associated caregivers, as it’s associated with higher monitoring of blood glucose and a decrease danger of issues. In line with the above, a subject for additional analysis may very well be represented by the combination of the HTA outcomes, particularly referring to the social dimensions, with particular patient-reported consequence measures (PROMs), thus investigating the extent of diabetes misery perceived by individuals dwelling with this persistent illness.
The principle energy of the current examine is that it gives a “real-life” image of the potential implications of GA within the Italian medical apply, thus giving an summary of the modification of the affected person medical pathway, with a consequent financial sources absorption estimation. It must be famous that, although outcomes may very well be influenced by Italian native points, the medical pathway is in line with the Worldwide Tips on the subject, with regard to the exams and procedures dedicated to individuals with diabetes, being, thus, generalizable. The one sample that might change worldwide, is the financial analysis of the only merchandise of healthcare expenditure (when it comes to tariffs and costs), even when the financial dimension, on the entire, may very well be replicable inside each NHS-based and insurance-based Nations, as demonstrated within the sensitivity evaluation, confirming the robustness of the outcomes.
Though GA has been studied over the previous few years, this in-vitro diagnostic check isn’t but extensively used within the European medical laboratory routine, and few business merchandise are but accessible in the marketplace for this check, thus requiring the necessity of a nationwide and worldwide consensus about medical laboratory procedures and the medical use of GA, and guaranteeing its inclusion in medical laboratory routines. Particularly, regardless of its confirmed medical effectiveness, GA check isn’t included in any Italian medical guideline and/or algorithm, thus requiring an in-depth analysis as already carried out in different Asian Nations.20
Nevertheless, the outcomes of the examine, in keeping with an HTA strategy helpful to validate the implementation of any progressive know-how, with the combination of medical and managerial info, make GA a promising marker to make use of for glycaemic management in individuals with T2DM, thus displaying the strategic relevance of GA, within the enchancment of the medical pathway of people with diabetes, freeing-up NHS sources, for private and non-private sector, additionally making certain a greater fairness and social profile for people with diabetes.
This may very well be in line with scientific suggestion accessible on the subject, actually each the American Diabetes Affiliation (ADA) and the European Affiliation Diabetes Examine (EASD) suggests a “patient-centred” administration of glycemic management in T2DM people, and the choice solely of biomarkers, comparable to GA, that might be capable to replicate the person well being standing, sustaining the steadiness between dangers and advantages.9
BIA, finances impression evaluation; CEA, cost-effectiveness evaluation; CEV, cost-effectiveness worth; DM, diabetes mellitus; Hb1Ac, glycated haemoglobin; HTA, Well being Know-how Evaluation; IVD, In vitro diagnostic; GA, glycated albumin; FPG, fasting plasma glucose; NHS, Nationwide Well being Service; T2, sort 2; T2DM, sort 2 diabetes mellitus.
Knowledge Sharing Assertion
Knowledge can be accessible upon affordable request.
Ethics Approval and Knowledgeable Consent
Not relevant, because the analysis exercise investigated solely the usual medical pathway dedicated to any T2DM people, with out accumulating human and smart information. Moreover, moreover the method mapping strategy used for the definition of the usual medical apply, clinicians’ perceptions have been collected in keeping with a qualitative questionnaire. All of the clinicians concerned voluntary accomplished the questionnaire, whose perceptions have been analyzed utilizing aggregated strategies, in accordance with the “EU Regulation n. 679 of 04.05.2016”.
Consent for Publication
All of the clinicians concerned have been conscious that the current analysis exercise had as foremost goal the publication of the outcomes, they usually gave their consent in disseminating their perceptions, in an aggregated and nameless method, in accordance with the “EU Regulation n. 679 of 04.05.2016”.
The Authors want to thank all of the professionals concerned, for his or her worthwhile help to finish the qualitative and quantitative questionnaires, resulting in the success of the current analysis exercise.
All authors made a big contribution to the work reported, whether or not that’s within the conception, examine design, execution, acquisition of information, evaluation and interpretation, or in all these areas; took half in drafting, revising or critically reviewing the article; gave ultimate approval of the model to be printed; have agreed on the journal to which the article has been submitted; and comply with be accountable for all points of the work.
There isn’t a funding to report.
Dr Antonio Nicolucci experiences grants from Astra Zeneca, grants from AlfaSigma, grants from Sanofi, grants from Medtronic, grants from Eli Lilly, grants from Novo Nordisk, grants from Pikdare, grants from Shionogi, grants from SOBI, outdoors the submitted work. Dr Emanuela Foglia experiences non-financial help from Instrumentation Laboratories – Werfen, private charges from Instrumentation Laboratories – Werfen, outdoors the submitted work. The authors declare that they haven’t any different conflicts of curiosity in reference to the submitted article.
1. Worldwide Diabetes Federation. IDF diabetes atlas – ninth version; 2019. Obtainable from: https://www.diabetes.org.br/publico/images/Atlas-IDF-2019.pptx.pdf.
2. Rodríguez-Gutiérrez R, Montori VM. Glycemic management for sufferers with sort 2 diabetes mellitus: our evolving religion within the face of proof. Circ Cardiovasc Qual Outcomes. 2016;9(5):504–512. doi:10.1161/CIRCOUTCOMES.116.002901
3. Moodahadu LS, Dhall R, Zargar AH, Bangera S, Ramani L, Katipally R. Tight glycemic management and cardiovascular results in sort 2 diabetic sufferers. Coronary heart Views. 2014;15(4):111–120. doi:10.4103/1995-705X.151084
4. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM; American Diabetes Affiliation. Checks of glycemia in diabetes. Diabetes Care. 2003;26(Suppl 1):S106–8.
5. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c check in analysis and prognosis of diabetic sufferers. Biomark Insights. 2016;11:95–104. doi:10.4137/BMI.S38440
6. Ohde S, Deshpande GA, Yokomichi H, et al. HbA1c monitoring interval in sufferers on remedy for secure sort 2 diabetes. A ten-year retrospective, open cohort examine. Diabetes Res Clin Pract. 2018;135:166–171. doi:10.1016/j.diabres.2017.11.013
7. World Well being Group. Use of glycated haemoglobin (HbA1c) within the analysis of diabetes mellitus abbreviated report of a WHO session. Geneva: World Well being Group; 2011.
8. Sacks DB. Hemoglobin A1c in diabetes: panacea or pointless? Diabetes. 2013;62(1):41–43. doi:10.2337/db12-1485
9. American Diabetes Affiliation. Requirements of medical care in diabetes. Diabetes Care. 2019;42(Complement 1):S1–S2. doi:10.2337/dc19-Sint01
10. Weykamp C. HbA1c: a evaluation of analytical and medical points. Ann Lab Med. 2013;33:393–400. doi:10.3343/alm.2013.33.6.393
11. Krhač M, Vučić Lovrenčić M. Replace on biomarkers of glycemic management. World J Diabetes. 2019;10(1):1–15. doi:10.4239/wjd.v10.i1.1
12. Furusyo N, Hayashi J. Glycated albumin and diabetes mellitus. Biochim Biophys Acta. 2013;1830(12):5509–5514. doi:10.1016/j.bbagen.2013.05.010
13. Koga M, Kasayama S. Scientific impression of glycated albumin as one other glycemic management marker. Endocr J. 2010;57(9):751–762. doi:10.1507/endocrj.K10E-138
14. Kosecki SM, Rodgers PT, Adams MB. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy. Ann Pharmacother. 2005;39(9):1557–1560. doi:10.1345/aph.1G010
15. Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparability of glycated albumin and hemoglobin A(1c) ranges in diabetic topics on hemodialysis. Kidney Int. 2008;73(9):1062–1068. doi:10.1038/ki.2008.25
16. Inaba M, Okuno S, Kumeda Y, et al.; Osaka CKD Skilled Analysis Group. Glycated albumin is a greater glycemic indicator than glycated hemoglobin values in hemodialysis sufferers with diabetes: impact of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18(3):896–903. doi:10.1681/ASN.2006070772
17. Desouza CV, Holcomb R, Rosentock J, et al. Outcomes of a examine evaluating glycated albumin to different glycemic indices. J Clin Endocrinol Metab. 2020;105(3):677–687. doi:10.1210/clinem/dgz087
18. Araki T, Ishikawa Y, Okazaki H, et al. Introduction of glycated albumin measurement for all blood donors and the prevalence of a excessive glycated albumin degree in Japan. J Diabetes Investig. 2012;3(6):492–497. doi:10.1111/j.2040-1124.2012.00224.x
19. Hsu P, Ai M, Kanda E, et al. A comparability of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan. Atherosclerosis. 2015;242(1):327–333. doi:10.1016/j.atherosclerosis.2015.07.037
20. Nakao T, Inaba M, Abe M, et al. Finest apply for diabetic sufferers on hemodialysis 2012. Ther Apher Dial. 2015;19:40–66. doi:10.1111/1744-9987.12299
21. MedTech Europe. European IVD Market statistics report; 2019. Obtainable from: https://www.medtecheurope.org/wp-content/uploads/2019/12/2019_MTE_European-IVD-Market-Statistics.pdf.
22. Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical gadgets and repealing Directive 98/79/EC and Fee Determination 2010/227/EU. Obtainable from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0746-20170505.
23. EUNetHTA. The HTA core mannequin, model 3.0; January 2016. Obtainable from: http://eunethta.eu/sites/5026.fedimbo.belgium.be/files/HTACoreModel3.0.pdf.
24. Huang X, Lin J, Demner-Fushman D. Analysis of PICO as a data illustration for medical questions. AMIA Ann Symp Proc. 2006;359–363.
25. Schardt C, Adams MB, Owens T, et al. Utilization of the PICO framework to enhance looking out PubMed for medical questions. BMC Med Inform Decis Mak. 2007;7:16. doi:10.1186/1472-6947-7-16
27. Quinn Patton M. Qualitative analysis & analysis strategies, third version. Sage publications; 2002.
28. Shima Ok, Komatsu M, Noma Y, Miya Ok. Glycated albumin (ga) is extra advantageous than hemoglobin a1c for evaluating the efficacy of sitagliptin in attaining glycemic management in sufferers with sort 2 diabetes. Intern Med. 2014;53:829–835. doi:10.2169/internalmedicine.53.1364
29. Italian Ministry of Well being. Outpatients/hospital admission Nationwide Reimbursement Tariffs. Obtainable from: https://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=28/01/2013&redaz=13A00528&artp=3&art=1&subart=1&subart1=10&vers=1&prog=001.
30. Istituto Nazionale di Statistica. Il diabete in Italia; 2017. Obtainable from: https://www.istat.it/it/files//2017/07/REPORT_DIABETE.pdf.
31. Associazione Medici Diabetologi. Le monografie degli Annali AMD. Diabete, Obesità e Malattia Cardiovascolare: lo state of affairs italiano; 2019. Obtainable from: http://aemmedi.it/wp-content/uploads/2019/01/Annali-AMD-2018-password.pdf.
32. Mitton C, Dionne F, Damji R, Campbell D, Bryan S. Tough selections in instances of constraint: standards primarily based useful resource allocation within the vancouver coastal well being authority. BMC Well being Serv Res. 2011;11(1):169. doi:10.1186/1472-6963-11-169
33. Berg B. Qualitative Analysis Strategies for the Social Sciences. MA: Pearsons Schooling Inc.; 2009.
34. Kitzinger J. Qualitative analysis. Introducing focus teams. Br Med J. 1995;311(7000):299. doi:10.1136/bmj.311.7000.299
35. Jansen H. The logic of qualitative survey analysis and its place within the subject of social analysis strategies. 2010.
36. Mullen PD, Reynolds R. The potential of grounded idea for well being training analysis: linking idea and apply. Well being Educ Behav. 1978;6(3):280–294.
37. Spiegelhalter DJ, Myles JP, Abrams KR. Bayesian Approaches to Scientific Trials and Well being-Care Analysis. New York: Wiley N.Y; 2003.
38. Bernardo JM, Smith AFM. Bayesian Concept. West Sussex, England: John Wiley & Sons Ltd; 1994.
39. Gained HK, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Discount in glycated albumin can predict change in hba1c: comparability of oral hypoglycaemic agent and insulin therapies. Diabet Med. 2012;29:74–79. doi:10.1111/j.1464-5491.2011.03386.x
40. Koga M, Murai J, Saito H, Kasayama S. Prediction of near-future glycated hemoglobin ranges utilizing glycated albumin ranges earlier than and after remedy for diabetes. J Diabetes Investig. 2011;2:304–309. doi:10.1111/j.2040-1124.2011.00107.x
41. Lu JM, Ji LN, Li YF, et al. Glycated albumin is superior to glycated hemoglobin for glycemic management evaluation at an early stage of diabetes remedy: a multicenter, potential examine. J Diabetes Issues. 2016;30:1609–1613. doi:10.1016/j.jdiacomp.2016.07.007
42. Li ZL, Liu JC, Liu SB, Li XQ, Yi DH, Zhao MG. Enchancment of vascular operate by acute and persistent remedy with the GPR30 agonist G1 in experimental diabetes mellitus. PLoS One. 2012;7(6).
43. Murea M, Moran T, Russell GB, et al. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and size of keep in diabetic sufferers on dialysis. Am J Nephrol. 2012;36(5):488–496. doi:10.1159/000343920
44. Music SO, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Serum glycated albumin predicts the development of carotid arterial atherosclerosis. Atherosclerosis. 2012;225(2):450–455. doi:10.1016/j.atherosclerosis.2012.09.005
45. Xue Y, Sheng Y, Dai H, Cao H, Liu Z, Li Z. Threat of improvement of acute pancreatitis with pre-existing diabetes: a meta-analysis. Eur J Gastroenterol Hepatol. 2012;24(9):1092–1098. doi:10.1097/MEG.0b013e328355a487
46. Giglio RV, Lo Sasso B, Agnello L, et al. Latest updates and advances in using glycated albumin for the analysis and monitoring of diabetes and renal, cerebro- and cardio-metabolic ailments. J Clin Med. 2020;9:3634. doi:10.3390/jcm9113634
47. Patti AM, Rizvi AA, Giglio RV, Stoian AP, Ligi D, Mannello F. Influence of glucose-lowering medicines on cardiovascular and metabolic danger in sort 2 diabetes. J Clin Med. 2020;9:912. doi:10.3390/jcm9040912
48. Gram-Hansen P, Eriksen J, Mourits-Andersen T, Olesen L. Glycosylated haemoglobin (HbA1c) in iron- and vitamin B12 deficiency. J Intern Med. 1990;227(2):133–136. doi:10.1111/j.1365-2796.1990.tb00131.x
49. Coban E, Ozdogan M, Timuragaoglu A. Impact of iron deficiency anemia on the degrees of hemoglobin A1c in nondiabetic sufferers. Acta Haematol. 2004;112(3):126–128. doi:10.1159/000079722
50. Church D, Simmons D. Extra proof of the issues of utilizing HbA1c for diagnosing diabetes? The recognized knowns, the recognized unknowns and the unknown unknowns. J Intern Med. 2014;276(2):171–173. doi:10.1111/joim.12200
51. Danese E, Montagnana M, Nouvenne A, Lippi G. Benefits and pitfalls of fructosamine and glycated albumin within the analysis and remedy of diabetes. J Diabetes Sci Technol. 2015;9(2):169–176. doi:10.1177/1932296814567227